iomeprol has been researched along with Canine Diseases in 2 studies
iomeprol: structure given in first source
iomeprol : A benzenedicarboxamide compound having N-substituted carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and a glycoloyl(methyl)amino group at the 5-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare the incidence of seizures in dogs with intervertebral disk disease after iopamidol or iomeprol myelography, and to assess whether the incidence of seizures differed between the 2 agents when severity of neurological deficits, location of cord compression, duration of anesthesia, site of myelogram, volume of contrast, and concentration of contrast were evaluated." | 7.75 | Incidence of seizures associated with iopamidol or iomeprol myelography in dogs with intervertebral disk disease: 161 cases (2000-2002). ( Dvorak, M; Kecova, H; Lexmaulova, L; Necas, A; Proks, P; Rauser, P; Srnec, R; Zatloukal, J, 2009) |
| "Ioxilan has the least arrythmogenic property among the current low-osmolality nonionic CMs." | 5.31 | The risk of contrast media-induced ventricular fibrillation is low in canine coronary arteriography with ioxilan. ( Fujiki, M; Misumi, K; Miura, N; Sakamoto, H; Tateno, O, 2000) |
| "To compare the incidence of seizures in dogs with intervertebral disk disease after iopamidol or iomeprol myelography, and to assess whether the incidence of seizures differed between the 2 agents when severity of neurological deficits, location of cord compression, duration of anesthesia, site of myelogram, volume of contrast, and concentration of contrast were evaluated." | 3.75 | Incidence of seizures associated with iopamidol or iomeprol myelography in dogs with intervertebral disk disease: 161 cases (2000-2002). ( Dvorak, M; Kecova, H; Lexmaulova, L; Necas, A; Proks, P; Rauser, P; Srnec, R; Zatloukal, J, 2009) |
| "Ioxilan has the least arrythmogenic property among the current low-osmolality nonionic CMs." | 1.31 | The risk of contrast media-induced ventricular fibrillation is low in canine coronary arteriography with ioxilan. ( Fujiki, M; Misumi, K; Miura, N; Sakamoto, H; Tateno, O, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lexmaulova, L | 1 |
| Zatloukal, J | 1 |
| Proks, P | 1 |
| Dvorak, M | 1 |
| Srnec, R | 1 |
| Rauser, P | 1 |
| Kecova, H | 1 |
| Necas, A | 1 |
| Misumi, K | 1 |
| Tateno, O | 1 |
| Fujiki, M | 1 |
| Miura, N | 1 |
| Sakamoto, H | 1 |
2 other studies available for iomeprol and Canine Diseases
| Article | Year |
|---|---|
Incidence of seizures associated with iopamidol or iomeprol myelography in dogs with intervertebral disk disease: 161 cases (2000-2002).
Topics: Animals; Cervical Vertebrae; Contrast Media; Dog Diseases; Dogs; Female; Intervertebral Disc Displac | 2009 |
The risk of contrast media-induced ventricular fibrillation is low in canine coronary arteriography with ioxilan.
Topics: Animals; Contrast Media; Coronary Angiography; Dog Diseases; Dogs; Female; Iohexol; Iopamidol; Male; | 2000 |